IMI (IMI) Q3 2025 TU earnings summary

Executive summary

• Organic revenue grew 12% year-over-year in Q3 and is up 5% year-to-date, reflecting strong execution and the effectiveness of the growth strategy.

• Full-year guidance for mid-single digit organic revenue growth reconfirmed, marking the fourth consecutive year of such performance.

• Strong balance sheet and cash generation support ongoing investment, acquisitions, and shareholder returns.

• Process automation delivered a standout quarter, with 26% sales growth driven by shipment phasing and robust demand in energy-related sectors.

• Climate control, industrial automation, and life science and fluid control sectors all performed well, with climate control maintaining a multi-year 4-5% growth rate.

Financial highlights

• Q3 statutory revenue increased 11% year-over-year, with organic revenue up 12%.

• Full-year EPS guidance reaffirmed at EUR 0.129–0.136 (129p–136p).

• Margins expected to reach 20% for the year, up from 14% in prior years, with a long-term target of 22%.

• Group organic revenue growth of 12% in Q3 included 2-3% from shipment catch-ups, mainly in life science and fluid control.

• Aftermarket orders in process automation rose 7% organically year-to-date, with a 1% increase in Q3 against a strong prior-year comparison.

Outlook and guidance

• Full-year EPS expected between EUR 0.129 and EUR 0.136.

• Mid-single-digit organic revenue growth targeted for next year, in line with current year trends.

• Exchange rates as of late October 2025 could reduce revenue by 1% and adjusted operating profit by 1.5% for the full year compared to 2024.

• Tax rate will rise to just over 26% next year, impacting EPS by about GBP 0.015 due to increased cyber investments.

• Life sciences expected to return to low single-digit growth next year, with potential for higher growth longer term.